Clinical Trial: Fructose Malabsorption in Northern Norway

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Fructose Malabsorption in Northern Norway. Fructose Malabsorption and Irritable Bowel Syndrome.

Brief Summary:

Different published studies has shown a possible co-variation between leakage of fructose to the great bowel and exacerbation of irritable bowel syndrome (IBS) symptoms.

The aim of the FINN trial is to study the role of fructose malabsorption in patients with IBS in order to evaluate different diagnostic criteria for fructose malabsorption and at the same time study the effect of diet treatment in this cohort of patients and estimate the prevalence of fructose malabsorption.

Detailed Summary:
Sponsor: University Hospital of North Norway

Current Primary Outcome: VAS score og specific abdominal complaints.SGA score of relief related to abdominal complaints. [ Time Frame: 12 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Estimate sensitivity,specificity,negative and positive predictive value using 50 gm fructose in breath test.Validate questionary for intolerance.Validate VAS in judging changes in abdominal complaint.Examine polymorphism i Glut5 transporter gene. [ Time Frame: 12 weeks ]

Original Secondary Outcome: Same as current

Information By: University Hospital of North Norway

Dates:
Date Received: November 6, 2007
Date Started: September 2007
Date Completion:
Last Updated: May 23, 2016
Last Verified: May 2016